M L Rao
Overview
Explore the profile of M L Rao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1078
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rao M, Strebel B, Gross G, Huber G
Amino Acids
. 2013 Nov;
2(1-2):111-8.
PMID: 24194278
Altered dopamine turnover has been postulated as underlying cause for schizophrenia. This is partially inferred from pharmacological studies and from changes in serum dopamine and dopamine metabolite levels. It is...
2.
Ostad Haji E, Tadic A, Wagner S, Dragivevic A, Muller M, Boland K, et al.
Pharmacopsychiatry
. 2013 Sep;
46(7):261-6.
PMID: 24065567
Introduction: Post hoc analyses of clinical trials have shown that early improvement around day 14 is highly predictive for later response. More-over, evidence has been given that sufficiently high concentrations...
3.
Dreimuller N, Tadic A, Dragicevic A, Boland K, Bondy B, Lieb K, et al.
Pharmacopsychiatry
. 2011 Nov;
45(3):108-13.
PMID: 22086748
Introduction: Both the serotonin transporter promotor polymorphism (5-HTTLPR) and serum concentrations of SSRIs have been shown to affect response to SSRIs. Results, however, are inconsistent. The aim of this study...
4.
Lewitzka U, Muller-Oerlinghausen B, Felber W, Brunner J, Hawellek B, Rujescu D, et al.
Acta Psychiatr Scand
. 2007 Nov;
117(1):41-9.
PMID: 18028252
Objective: Low platelet monoaminoxidase B (MAO-B) activity has been associated with various forms of impulsive behaviour and suicidality. The present study investigated the relationship between MAO-B activity in platelets and...
5.
Baumann P, Hiemke C, Ulrich S, Eckermann G, Kuss H, Laux G, et al.
Rev Med Suisse
. 2006 Jun;
2(67):1413-8, 1420-2, 1424-6.
PMID: 16786958
In psychiatry, therapeutic drug monitoring (TDM) is an established procedure for most psychotropic drugs. However, as its use in everyday clinical practice is far from optimal, the AGNP-TDM group has...
6.
Grasmader K, Verwohlt P, Kuhn K, Frahnert C, Hiemke C, Dragicevic A, et al.
Pharmacopsychiatry
. 2005 May;
38(3):113-7.
PMID: 15902580
Objective: The aim of this study was to evaluate the benefit of mirtazapine plasma concentration monitoring in a typical clinical setting. Methods: The relationship between mirtazapine plasma concentration, dose, response,...
7.
Kuhn K, Joe A, Meyer K, Reichmann K, Maier W, Rao M, et al.
Pharmacopsychiatry
. 2004 Nov;
37(6):286-91.
PMID: 15551195
Background: The human 5-HT (2C) receptor gene has been localized on the X chromosome and is expressed in two genetic variants. Whereas previous investigations have suggested that the 5-HT (2C)...
8.
Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, et al.
Pharmacopsychiatry
. 2004 Nov;
37(6):243-65.
PMID: 15551191
Therapeutic Drug Monitoring (TDM) is a valid tool to optimise pharmacotherapy. It enables the clinician to adjust the dosage of drugs according to the characteristics of the individual patient. In...
9.
Feuchtl A, Bagli M, Stephan R, Frahnert C, Kolsch H, Kuhn K, et al.
Pharmacopsychiatry
. 2004 Oct;
37(4):180-8.
PMID: 15467976
Introduction: Serotonin plays an important role in psychiatric diseases, most notably in depression and anxiety. Seven different major serotonin receptor subtypes have been described. Receptor-selective agonists and antagonists have been...
10.
Baumann P, Hiemke C, Ulrich S, Gaertner I, Rao M, Eckermann G, et al.
Ther Drug Monit
. 2004 Jul;
26(2):167-70.
PMID: 15228159
TDM of psychotropic drugs is widely used, but there is little consensus regarding its optimal use in the clinical context. This prompted a multidisciplinary group comprised of clinical biochemists, clinical...